Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Acquires Rights to Biocon Insulin Products for $200 Million Upfront
Pfizer Acquires Rights to Biocon Insulin Products for $200 Million Upfront
Pfizer Acquires Rights to Biocon Insulin Products for $200 Million Upfront
Submitted by
admin
on October 18, 2010 - 9:54am
Source:
Bloomberg
News Tags:
M&A
Pfizer
Biocon
insulin
Headline:
Pfizer Acquires Rights to Biocon Insulin Products for $200 Million Upfront
Do Not Allow Advertisers to Use My Personal information
